Clinical Trial Update: Clinical Trial to Study the Safety and Tolerability of Memantin Mepha® in Sickle Cell Disease Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and tolerability of Memantin Mepha in adults with sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Memantin Mepha (memantine)

Snippet

Sponsor: University of Zurich | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED